First monkeys, and then us? Human cloning must stay off limits
By Marcy Darnovsky,
New Scientist
| 01. 24. 2018
Remember the human cloning controversies of the early 2000s? One reason they faded was that scientists were unable to clone non-human primates. Now that researchers have produced two cloned monkeys, we should brace ourselves for a rerun of arguments in favour of human clones. But human reproductive cloning would be every bit as misguided and dangerous now as it was then.
As long ago as 1971, James Watson of double helix fame warned in The Atlantic about the prospect of “Moving Toward the Clonal Man”. He later changed his mind and began promoting human reproductive cloning, as well as suggesting that human germline modification could tackle stupidity and ensure all women are “pretty”.
In 1997, headlines announced that scientists in the UK had created what had long been considered biologically impossible: a cloned mammal, a sheep dubbed “Dolly”. Debate about creating human clones immediately followed. Time, for example, put Dolly on its cover the following month and posed the question: “Will There Ever Be Another You?”
A few mavericks claimed to be on the verge...
Related Articles
By Sarojini Nadimpally and Gargi Mishra, The Wire | 12.15.2024
In-vitro fertilisation (IVF) as assisted reproductive technology (ART) has been in vogue for quite a few decades now. While IVF has been hailed as a significant scientific advancement, with many advantages, here are some limitations which bear keeping in mind...
Image by Mohamed Hassan from Pixabay
It is hard to make predictions, especially about the future, as Yogi Berra, Niels Bohr, and other luminaries have remarked. But there are already signs that the incoming Trump administration may have some difficulty establishing consistent policies about controversial issues concerning human reproduction.
On the one hand, consider “the conservative blueprint for a second Trump administration.”
The notorious Project 2025’s Mandate for Leadership seeks to delete terms such as “reproductive rights” from “every federal...
By Susan Dominus, The New York Times | 11.30.2024
In the days after Daphna Cardinale delivered her second child, she experienced a rare sense of calm and wonder. The feeling was a relief after so much worrying: She and her husband, Alexander, had tried for three years to conceive...
By Christy Santhosh, Reuters | 11.27.2024
Nov 27 (Reuters) - The U.S. Food and Drug Administration is weighing the need for regulatory action on bluebird bio's (BLUE.O), opens new tab gene therapy for a rare neurological disorder, it said on Wednesday, as the agency probes additional...
